导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.50% | 280/923 |
| 近一周 | 0.02% | 441/970 |
| 近一月 | 0.10% | 69/957 |
| 近一季 | 0.41% | 226/953 |
| 近半年 | 0.72% | 203/937 |
| 近一年 | 1.61% | 284/920 |
| 近两年 | 4.34% | 593/819 |
| 近三年 | 7.76% | 458/693 |
| 成立以来 | 21.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.34% 99/917 |
0.49% 784/957 |
0.31% 167/973 |
- - |
| 2024 | 2.57% 647/908 |
0.83% 531/846 |
0.68% 663/862 |
0.37% 160/878 |
0.67% 785/908 |
| 2023 | 3.27% 386/832 |
1.09% 262/751 |
0.84% 521/771 |
0.62% 275/802 |
0.68% 642/832 |
| 2022 | 2.60% 111/729 |
0.92% 57/525 |
0.91% 207/610 |
0.61% 425/652 |
0.13% 243/729 |
| 2021 | 4.40% 56/489 |
0.84% 108/330 |
1.06% 74/361 |
1.32% 52/413 |
1.11% 50/489 |
| 2020 | 2.50% 144/351 |
1.14% 146/251 |
0.45% 52/292 |
0.13% 224/302 |
0.75% 125/329 |
| 2019 | 3.09% 91/249 |
0.67% 1395/1682 |
0.98% 233/1825 |
0.84% 116/207 |
0.56% 190/237 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 国泰利享中短债债券A VS. () |